{"id":346504,"date":"2026-08-20T16:59:25","date_gmt":"2026-08-20T16:59:25","guid":{"rendered":"https:\/\/www.europesays.com\/se\/346504\/"},"modified":"2026-08-20T16:59:25","modified_gmt":"2026-08-20T16:59:25","slug":"moderna-rusar-over-100-pa-cancervaccin","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/346504\/","title":{"rendered":"Moderna rusar \u00f6ver 100% p\u00e5 cancervaccin"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\"><strong>Moderna <\/strong>handlas upp drygt 115% i handeln p\u00e5 <strong>Nasdaq<\/strong> under onsdagen. Av 25 analytiker hade bara fem k\u00f6prekommendationer. Analytikerna hade med andra ord skrivit av bolaget, som tappat stort i takt med att int\u00e4kterna fr\u00e5n covidvaccin f\u00f6rsvunnit.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Beskedet som v\u00e4nde allt \u00e4r resultatet fr\u00e5n en ny studie. Den omfattar 1 137 patienter med hudcancerformen melanom. <\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Patienterna fick antingen Modernas vaccin intismeran autogene tillsammans med <strong>Mercks <\/strong>immunterapi Keytruda, eller enbart Keytruda.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Kombinationen minskade b\u00e5de risken f\u00f6r att cancern kommer tillbaka och risken f\u00f6r att den sprider sig till andra organ. Studien stoppades redan vid den f\u00f6rsta delanalysen eftersom skillnaden var tillr\u00e4ckligt tydlig. Merck stiger omkring 8% i f\u00f6rhandeln.<\/p>\n<p class=\"font-sans text-xs font-normal uppercase leading-[1.3] self-start text-text-brand dark:text-text-brand-dark\">Fakta<\/p>\n<p>S\u00e5 fungerar vaccinet<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Det h\u00e4r \u00e4r inget vaccin som ges i f\u00f6rebyggande syfte till friska. Varje dos tillverkas f\u00f6r en enskild patient. L\u00e4karna analyserar patientens egen tum\u00f6r, letar upp de mutationer som g\u00f6r just den tum\u00f6ren unik och bygger sedan ett mRNA-recept utifr\u00e5n dem. Vaccinet fungerar som en efterlysning till immunf\u00f6rsvaret, som l\u00e4r sig k\u00e4nna igen och angripa de cancerceller som eventuellt finns kvar i kroppen efter operationen. Tekniken \u00e4r densamma som i covidvaccinen, men anv\u00e4nds h\u00e4r f\u00f6r att jaga celler som redan finns p\u00e5 plats.<\/p>\n","protected":false},"excerpt":{"rendered":"Moderna handlas upp drygt 115% i handeln p\u00e5 Nasdaq under onsdagen. Av 25 analytiker hade bara fem k\u00f6prekommendationer.&hellip;\n","protected":false},"author":2,"featured_media":346505,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[65],"tags":[34343,4352,72,70,71,12313,12308,15205,39004,12307,34,31,33,32,30,39003],"class_list":["post-346504","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ekonomi","tag-biontech","tag-bioteknik","tag-business","tag-economy","tag-ekonomi","tag-lakemedelsbolag","tag-merck","tag-moderna","tag-nykode-therapeutics","tag-roche","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish","tag-transgene-s-a"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/117128905766991029","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/346504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=346504"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/346504\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/346505"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=346504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=346504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=346504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}